These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14057524)

  • 1. BIOCHEMICAL ASPECTS OF COPPER AND AROMATIC AMINES IN RELATION TO THE EXTRAPYRAMIDAL SYSTEM.
    WALAAS E; WALAAS O
    Acta Neurol Scand Suppl; 1963; 39(4):SUPPL4:84-94. PubMed ID: 14057524
    [No Abstract]   [Full Text] [Related]  

  • 2. A QUANTITATIVE SIMOLA TEST AND ITS APPLICATION TO THE INVESTIGATION OF EXTRAPYRAMIDAL SYNDROMES.
    CURZON G; WALD I
    Clin Chim Acta; 1963 Nov; 8():893-901. PubMed ID: 14089561
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical aspects of hepatolenticular degeneration. Study of the "turnover" of copper in some extrapyramidal syndromes].
    Agnoli A; Casacchia M; Fieschi C
    Recenti Prog Med; 1970 Oct; 49(4):385-98. PubMed ID: 5537615
    [No Abstract]   [Full Text] [Related]  

  • 4. [HEPATOLENTICULAR DEGENERATION, ACUTE ANEMIA AND HEPATIC INSUFFICIENCY LONG PRECEDING THE NEUROLOGICAL SYMPTOMS].
    TURPIN R; CAILLE B; LAFOURCADE J; JEROME H; BOUTELIER D; DEFRANOUX A
    Ann Pediatr (Paris); 1963; 10():277-83. PubMed ID: 14126013
    [No Abstract]   [Full Text] [Related]  

  • 5. THE CLASSIFICATION OF THE DISEASES OF THE EXTRAPYRAMIDAL SYSTEM.
    BAUMANN J
    Acta Neurol Scand Suppl; 1963; 39(4):SUPPL4:102-7. PubMed ID: 14057495
    [No Abstract]   [Full Text] [Related]  

  • 6. [AMINOACIDURIAS IN PATIENTS WITH PSYCHIATRIC DISORDERS AND OTHER RELATED STATES].
    CHEDIDTURBAY A
    Med Trop (Madr); 1964; 40():36-87. PubMed ID: 14132714
    [No Abstract]   [Full Text] [Related]  

  • 7. DISTURBANCES OF COPPER AND AMINO ACID METABOLISM IN CLINICALLY HEALTHY RELATIVES OF PATIENTS WITH HEPATOLENTICULAR DEGENERATION.
    PATRUNOVA VP
    Fed Proc Transl Suppl; 1964; 23():340-2. PubMed ID: 14145670
    [No Abstract]   [Full Text] [Related]  

  • 8. Extrapyramidal symptoms in Wilson's disease are associated with olfactory dysfunction.
    Mueller A; Reuner U; Landis B; Kitzler H; Reichmann H; Hummel T
    Mov Disord; 2006 Sep; 21(9):1311-6. PubMed ID: 16763975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HEPATOLENTICULAR DEGENERATION; CLINICAL AND BIOCHEMICAL STUDY OF THREE CASES.
    CANELAS HM; ESCALANTE OD; DE JORGE FB; ROCHA-QINTAO EC
    Arq Neuropsiquiatr; 1963 Dec; 21():229-50. PubMed ID: 14119988
    [No Abstract]   [Full Text] [Related]  

  • 10. Relation of ceruloplasmin and plasma copper to hepatolenticular degeneration (Wilson's disease).
    SCHEINBERG IH
    Prog Neurobiol (1956); 1956; 1():52-63. PubMed ID: 13359521
    [No Abstract]   [Full Text] [Related]  

  • 11. [Features of the course and disorders of copper and ceruloplasmin metabolism in hepatolenticular degeneration].
    Davidenkova EF; Neĭfakh SA; Butomo IV; Mashkov BA; Lapchenkov VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):982-90. PubMed ID: 5598796
    [No Abstract]   [Full Text] [Related]  

  • 12. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CLINICAL AND PATHOLOGICAL CHARACTERISTICS IN WILSON'S DISEASE IN CASES UNDER TEN YEARS OF AGE.
    ARIMA M; KOMIYA K; KAMOSHITA S; MUKAI N
    Paediatr Univ Tokyo; 1963 Dec; 9():17-22. PubMed ID: 14157269
    [No Abstract]   [Full Text] [Related]  

  • 14. Biological functions of ceruloplasmin and their deficiency caused by mutation in genes regulating copper and iron metabolism.
    Mzhel'skaya TI
    Bull Exp Biol Med; 2000 Aug; 130(8):719-27. PubMed ID: 11177225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BILIARY EXCRETION FOF CAERULOPLASMIN COPPER.
    AISEN P; MORELL AG; ALPERT S; STERNLIEB I
    Nature; 1964 Aug; 203():873-4. PubMed ID: 14204078
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome.
    MARKOWITZ H; GUBLER CJ; MAHONEY JP; CARTWRIGHT GE; WINTROBE MM
    J Clin Invest; 1955 Oct; 34(10):1498-508. PubMed ID: 13263429
    [No Abstract]   [Full Text] [Related]  

  • 17. HEPATOLENTICULAR DEGENERATION: OBSERVATIONS ON A CASE TREATED WITH D-PENICILLAMINE.
    HERRING VG; KLATSKIN G; BRANDT IK
    J Pediatr; 1963 Oct; 63():550-60. PubMed ID: 14074413
    [No Abstract]   [Full Text] [Related]  

  • 18. [COPPER METABOLISM AND WILSON'S DISEASE].
    LANGE J
    Verh Dtsch Ges Inn Med; 1964; 70():330-7. PubMed ID: 14294237
    [No Abstract]   [Full Text] [Related]  

  • 19. [THE BEHAVIOR OF BRAIN ENZYMES IN DISEASES OF THE EXTRAPYRAMIDAL MOTOR SYSTEM].
    HARTMANN-VONMONAKOW K
    Schweiz Arch Neurol Neurochir Psychiatr; 1963; 92():415-6. PubMed ID: 14059163
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on copper metabolism. XXIX. A critical analysis of serum copper and ceruloplasmin concentrations in normal subjects, patients with Wilson's disease and relatives of patients with Wilson's disease.
    CARTWRIGHT GE; MARKOWITZ H; SHIELDS GS; WINTROBE MM
    Am J Med; 1960 Apr; 28():555-63. PubMed ID: 13808058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.